159 related articles for article (PubMed ID: 36429010)
1. Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF.
Wang H; Zhang H; Chen Y; Wang H; Tian Y; Yi X; Shi Q; Zhao T; Zhang B; Gao T; Guo S; Li C; Guo W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429010
[TBL] [Abstract][Full Text] [Related]
2. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer.
Wang Y; Zheng L; Shang W; Yang Z; Li T; Liu F; Shao W; Lv L; Chai L; Qu L; Xu Q; Du J; Liang X; Zeng J; Jia J
Cell Death Differ; 2022 Nov; 29(11):2190-2202. PubMed ID: 35534546
[TBL] [Abstract][Full Text] [Related]
3. Pannexin 1 binds β-catenin to modulate melanoma cell growth and metabolism.
Sayedyahossein S; Huang K; Li Z; Zhang C; Kozlov AM; Johnston D; Nouri-Nejad D; Dagnino L; Betts DH; Sacks DB; Penuela S
J Biol Chem; 2021; 296():100478. PubMed ID: 33647315
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1-Wnt/β-catenin-TFE3 feedback loop signalling.
Luo Y; Huang S; Wei J; Zhou H; Wang W; Yang J; Deng Q; Wang H; Fu Z
Clin Transl Med; 2022 Apr; 12(4):e752. PubMed ID: 35485210
[TBL] [Abstract][Full Text] [Related]
5. The MITF regulatory network in melanoma.
Chauhan JS; Hölzel M; Lambert JP; Buffa FM; Goding CR
Pigment Cell Melanoma Res; 2022 Sep; 35(5):517-533. PubMed ID: 35771179
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798
[TBL] [Abstract][Full Text] [Related]
7. The tumor promoter cysteinyl leukotriene receptor 1 regulates PD-L1 expression in colon cancer cells via the Wnt/β-catenin signaling axis.
Satapathy SR; Ghatak S; Sjölander A
Cell Commun Signal; 2023 Jun; 21(1):138. PubMed ID: 37316937
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors.
Tao Q; Liu N; Wu J; Chen J; Chen X; Peng C
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471712
[TBL] [Abstract][Full Text] [Related]
9. Targeting Wnt signaling for improved glioma immunotherapy.
Gutova M; Hibbard JC; Ma E; Natri HM; Adhikarla V; Chimge NO; Qiu R; Nguyen C; Melendez E; Aguilar B; Starr R; Yin H; Rockne RC; Ono M; Banovich NE; Yuan YC; Brown CE; Kahn M
Front Immunol; 2024; 15():1342625. PubMed ID: 38449858
[TBL] [Abstract][Full Text] [Related]
10. Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence.
Kluge V; Kappelmann-Fenzl M; Fischer S; Zimmermann T; Pommer M; Kuphal S; Bosserhoff AK
Cell Death Dis; 2024 Feb; 15(2):166. PubMed ID: 38388496
[TBL] [Abstract][Full Text] [Related]
11. Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics.
Pandey P; Khan F; Seifeldin SA; Alshaghdali K; Siddiqui S; Abdelwadoud ME; Vyas M; Saeed M; Mazumder A; Saeed A
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432240
[TBL] [Abstract][Full Text] [Related]
12. A
Wang J; Zheng X; Fu X; Jiang A; Yao Y; He W
Theranostics; 2023; 13(11):3844-3855. PubMed ID: 37441586
[TBL] [Abstract][Full Text] [Related]
13. The Wnts of change: How Wnts regulate phenotype switching in melanoma.
Webster MR; Kugel CH; Weeraratna AT
Biochim Biophys Acta; 2015 Dec; 1856(2):244-51. PubMed ID: 26546268
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer.
Suryawanshi A; Tadagavadi RK; Swafford D; Manicassamy S
Front Immunol; 2016; 7():460. PubMed ID: 27833613
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis as a promising therapeutic strategy for melanoma.
Ta N; Jiang X; Zhang Y; Wang H
Front Pharmacol; 2023; 14():1252567. PubMed ID: 37795022
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
Zheng S; Guan XY
Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
[TBL] [Abstract][Full Text] [Related]
17. BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition.
Meng Y; Sun HY; He Y; Zhou Q; Liu YH; Su H; Yin MZ; Zeng FR; Chen X; Deng GT
Mil Med Res; 2023 Dec; 10(1):61. PubMed ID: 38049916
[No Abstract] [Full Text] [Related]
18. Discovery of small molecule β-catenin suppressors that enhance immunotherapy.
Feng X; Ge J; Fu H; Miao L; Zhao F; Wang J; Sun Y; Li Y; Li Y
Bioorg Chem; 2023 Oct; 139():106754. PubMed ID: 37536216
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-specific melanoma uptake of fatty acid from human adipocytes activates AXL and CAV1-dependent β-catenin nuclear accumulation.
Chocarro-Calvo A; Jociles-Ortega M; García-Martinez JM; Louphrasitthiphol P; Garcia YV; Ramírez-Sánchez A; Chauhan J; Fiuza MC; Duran M; García-Jiménez C; Goding CR
bioRxiv; 2024 Jan; ():. PubMed ID: 38328032
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis: friend or foe in cancer immunotherapy?
Demuynck R; Efimova I; Catanzaro E; Krysko DV
Oncoimmunology; 2023; 12(1):2182992. PubMed ID: 36875549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
